CD19 and acute lymphoblastic leukemia: Moreover, CD19 is a crucial marker for lineage assignment of blasts as per World Health Organization’s (WHO) guidelines (WHO blue book) and is present in almost all cases of B-ALL, making it the perfect target for CAR-Ts.